Treatments on the horizon for myasthenia gravis
| Complement inhibitor |
| Zilucoplan |
| Neonatal Fc receptor inhibitors |
| Batoclimab |
| Nipocalimab |
| Rozanolixizumab |
| B-lymphocyte depletion therapy |
| Obinutuzumab |
| Ofatumumab |
| Ublituximab |
| Blinatumomab |
| Inebilizumab |
| Cytokine inhibitor |
| Tocilizumab |
| Janus kinase inhibitors |
| Ruxolitinib |
| Baricitinib |
| Tofacitinib |
| Hematopoietic stem cell transplantation |
| Chimeric antigen receptor T-cell therapy |